CBS 2019
CBSMD教育中心
中 文

二尖瓣/三尖瓣瓣膜

Abstract

Recommended Article

Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction Patient and Hospital Characteristics of Mitral Valve Surgery in the United States Adaptive development of concomitant secondary mitral and tricuspid regurgitation after transcatheter aortic valve replacement Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study Thrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement Pathophysiology, diagnosis and new therapeutic approaches for ischemic mitral regurgitation Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death: A Review

Original Research

JOURNAL:CBSMD Article Link

多模态影像在心血管领域的应用

CBSMD

Pre-reading

为进一步促进临床决策的标准化,1月7日,由ACC、AHA等正式联合发表了“ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease”。该适当使用准则通过模拟102种相互独立的结构性心脏病、心肌病、心衰、主动脉瘤/夹层、肺动脉高压、心律不齐/器械治疗、心脏移植等临床场景,对TTE、TEE、负荷超声、多普勒、超声应变率显像、CMR、CT等多模态影像手段进行评分,指出与非瓣膜心脏病诊断相匹配的影像手段。


评分最低1分,最高9分:

评分结果7-9分,该影像学被公认为适用于该临床场景;

评分结果4-6分,该影像学被公认为可用于该临床场景;

评分结果1-3分,该影响学很少用于该临床场景。


《欧洲心脏杂志》在2019年2月初刊登了欧洲心血管影像协会( European Association of Cardiovascular Imaging , EACVI)对多模态影像在心血管领域的应用声明Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging”,在介绍心脏超声、核磁共振成像(CMR)、CT、CT/CMR的原理、主要特性及心血管应用的基础上,通过多模态影像参与的临床实例,具体说明其在心血管疾病诊断及治疗策略中的参与深度。该声明的核心在于倡导在欧洲范围内广泛推广多模态影像,鉴于各医院间发展的不均衡性,其中的部分推荐仅起概念性引导作用。